2016 - Webinar on Continued Process Verification - Process Monitoring
Date2016-03-10
Deadline2016-03-10
VenueMississauga, Canada
KeywordsProcess Verification; Process Monitoring; FDA Process Validation
Topics/Call fo Papers
Description :
The FDA’s Process Validation Guidance calls for “Continued Process Verification” in Stage 3 of the Guidance which focuses on continual assessment of process performance and product quality throughout the life of the product. Combining process control with process improvement creates a system that satisfies the direction of ICH Q8 (R2) and FDA’s guidance for continued process verification, continuous improvement and life cycle management. This presentation describes a disciplined and structured “Quality by Design” approach to achieve this objective.
The QbD “Design Space” concept has been given much attention by pharma and biotech industries but much less attention has been given to implementation of “process control” systems needed to keep the process in-control and consistently producing quality product. Process data are routinely analyzed at two levels to assess process stability and capability. During the production of each batch data are collected by the process operators and Quality Control to assure within batch stability and capability and that appropriate actions are taken when needed. On a monthly or quarterly basis, the batch-to-batch variation in product parameters is analyzed to assess the long-term stability and capability of the process. This system is illustrated and discussed in detail. Critical questions and challenges are identified. Connections of this system to process robustness are also addressed.
Areas Covered in the Session :
FDA Guidance regarding Process Validation and Continued Process Verification
Building Blocks of QbD ? Design Space, Process Control and Assessing Risk
Process Control Strategy - Stability and Capability Methods
Process Performance and Product Quality - A Systems Approach
The Vision for Process Monitoring and Control Building Blocks
Successful Deployment, Getting Started and Sustaining the Initiative
Tips and traps ? What to watch out for
Who Will Benefit:
Executives and Managers of Pharma and Biotech Companies
Process and Manufacturing Engineers
Quality Assurance Personnel
Regulatory Affairs Professionals
Quality Control Lab Personnel
Quality Engineers
Research and Development Scientists
Biologists and Microbiologists
Chemists and Chemical Engineers
For more information and enquiries contact us at
Compliance Trainings
5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support : #416-915-4458
Email : support-AT-compliancetrainings.com
For more information about this event please visit
https://compliancetrainings.com/SiteEngine/Product...
The FDA’s Process Validation Guidance calls for “Continued Process Verification” in Stage 3 of the Guidance which focuses on continual assessment of process performance and product quality throughout the life of the product. Combining process control with process improvement creates a system that satisfies the direction of ICH Q8 (R2) and FDA’s guidance for continued process verification, continuous improvement and life cycle management. This presentation describes a disciplined and structured “Quality by Design” approach to achieve this objective.
The QbD “Design Space” concept has been given much attention by pharma and biotech industries but much less attention has been given to implementation of “process control” systems needed to keep the process in-control and consistently producing quality product. Process data are routinely analyzed at two levels to assess process stability and capability. During the production of each batch data are collected by the process operators and Quality Control to assure within batch stability and capability and that appropriate actions are taken when needed. On a monthly or quarterly basis, the batch-to-batch variation in product parameters is analyzed to assess the long-term stability and capability of the process. This system is illustrated and discussed in detail. Critical questions and challenges are identified. Connections of this system to process robustness are also addressed.
Areas Covered in the Session :
FDA Guidance regarding Process Validation and Continued Process Verification
Building Blocks of QbD ? Design Space, Process Control and Assessing Risk
Process Control Strategy - Stability and Capability Methods
Process Performance and Product Quality - A Systems Approach
The Vision for Process Monitoring and Control Building Blocks
Successful Deployment, Getting Started and Sustaining the Initiative
Tips and traps ? What to watch out for
Who Will Benefit:
Executives and Managers of Pharma and Biotech Companies
Process and Manufacturing Engineers
Quality Assurance Personnel
Regulatory Affairs Professionals
Quality Control Lab Personnel
Quality Engineers
Research and Development Scientists
Biologists and Microbiologists
Chemists and Chemical Engineers
For more information and enquiries contact us at
Compliance Trainings
5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support : #416-915-4458
Email : support-AT-compliancetrainings.com
For more information about this event please visit
https://compliancetrainings.com/SiteEngine/Product...
Other CFPs
- Webinar on The FDA Drug Approval Process
- Webinar on ISO 13485 2016 utilizing Principles of Lean Documents and Lean Configuration
- Webinar on Corrective and Preventive Action (CAPA) utilizing the Principles of Lean Documents and Lean Configuration
- Webinar on Computer System Validation
- Webinar on Preparing For The FLSA Regulations
Last modified: 2016-02-25 21:32:21